Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02662335 · ClinicalTrials.gov registry record · NA
Computerized Cognitive Retraining in Improving Cognitive Function in Breast Cancer Survivors
A NA study of Stage IIIA Breast Cancer and Cancer Survivor, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT02662335 is a NA study of Stage IIIA Breast Cancer and Cancer Survivor that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 15 participants, below the 281-participant average among 29 other Stage IIIA Breast Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02662335, a NA study of Stage IIIA Breast Cancer and Cancer Survivor, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized clinical trial studies computerized cognitive retraining in improving cognitive function in breast cancer survivors. Cancer-related cognitive deficits, such as thinking and memory issues, are common among breast cancer survivors. The severity of these cognitive deficits is associated with a significant negative impact on daily function and quality of life. A computerized cognitive retraining method may help researchers find ways to improve cognitive function and quality of life in breast cancer survivors.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Computer-Assisted Cognitive Training
- PROCEDURE Standard Follow-Up Care
Study Locations (1)
Washington
- Fred Hutch/University of Washington Cancer Consortium - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2016-05 |
| Est. Completion | 2017-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02662335
The ClinicalTrials.gov registry entry for NCT02662335 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 281-participant average among 29 other Stage IIIA Breast Cancer trials with a reported enrollment target (95% lower). The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Stage IIIA Breast Cancer appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT02662335 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT02662335 about?
NCT02662335 is a clinical study titled "Computerized Cognitive Retraining in Improving Cognitive Function in Breast Cancer Survivors". This randomized clinical trial studies computerized cognitive retraining in improving cognitive function in breast cancer survivors. Cancer-related cognitive deficits, such as thinking and memory issues, are common among breast cancer survivors. The severity of these cognitive deficits is associated...
What is the current status of trial NCT02662335?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2016-05. Estimated completion is 2017-11-30.
What conditions does trial NCT02662335 study?
This clinical trial studies the following conditions: Stage IIIA Breast Cancer, Cancer Survivor, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IIA Breast Cancer.
What interventions are being tested in trial NCT02662335?
The interventions under investigation include: Questionnaire Administration (OTHER), Computer-Assisted Cognitive Training (OTHER), Standard Follow-Up Care (PROCEDURE).
Who is sponsoring clinical trial NCT02662335?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02662335 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage IIIA Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)
ACTIVE NOT RECRUITING · NA
-
Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer
COMPLETED · NA
-
Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors
COMPLETED · NA
-
FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer
COMPLETED · NA
-
Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy in Patients With Stage II-III Breast Cancer
COMPLETED · NA
-
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.